Clinical Trial Update: BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid Tumors [Phase 1]

View source ↗

Summary

This is a Phase 1 trial evaluating BGB-43395 alone or in combination for advanced breast cancer and other solid tumors. Recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Hormone Receptor-positive Breast Cancer
• Non-small Cell Lung Cancer

Drugs mentioned

• BGB-43395

Snippet

Sponsor: BeOne Medicines | Conditions: Advanced Solid Tumor, Advanced Breast Cancer | Phase 1 | Status: RECRUITING